Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Drug Development

      CHMP Recommends Approval of Dupixent for Severe Chronic Rhinosinusitis with Nasal Polyposis

      FDA Approvals
      Regeneron Pharmaceuticals, Inc. and Sanofi announced that the European Medicines Agency'sCommittee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for...

      Constellation Pharmaceuticals Advances CPI-0209 into Clinical Trials, Expanding its EZH2 Franchise

      Clinical Trials
      Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, announced that the Company has dosed...

      Incyte Announces First Patient Treated in Phase 3 Clinical Trial Program Evaluating Ruxolitinib Cream in Patients with Vitiligo

      Clinical Trials
      Incyte announced that the first patient has been treated in the Phase 3 TRuE-V clinical trial program evaluating the safety and efficacy of ruxolitinib...

      iOmx Therapeutics Announces Discovery of Novel, Druggable Immune-Checkpoint Targets

      Drug Development
      iOmx Therapeutics AG (iOmx), a biopharmaceutical company developing cancer therapeutics based on novel immune checkpoint targets, announced the presentation of two posters at the...

      Vineti and Cryoport Collaborate to Bring Integrated Solutions to the Global Regenerative Therapy Market

      Drug Development
      Vineti, Inc., and  Cryoport, Inc. announced a commercial partnership designed to extend end-to-end delivery of cell therapies and gene therapies to a growing number...

      Catalent To Open New Clinical Supply Facility In San Diego

      Drug Development
      Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, announced it...

      Roxadustat approved in China for the treatment of anaemia in non-dialysis-dependent patients with chronic kidney disease

      Drug Development
      AstraZeneca announced that its partner FibroGen (China) Medical Technology Development Co., Ltd. (FibroGen China) has received marketing authorisation for roxadustat in China for the...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.